Green Hornet stung again
This article was originally published in The Tan Sheet
Executive Summary
FDA expands upon February consumer alert on the street drug alternative Green Hornet to include "all other products by Cytotech Solutions," agency announces April 9. In analyses of additional Cytotech products, FDA identified presence of diphendydramine HCl, dextromethorphan, ephedrine and the controlled substances GBL and GHB. The products include Snuffadelic, Liquid Speed and Trip2Night. "Although the company is no longer producing these products, they remain under investigation," FDA says, adding it "is issuing this warning because consumers may still have these products in their possession," agency notes. FDA issued the Green Hornet alert after four teenagers were hospitalized with excessive heart rates and high blood pressure after taking the liquid manufactured by Cytotech and marketed by Kekio (1"The Tan Sheet" March 1, 2004, p. 15)...
You may also be interested in...
Green Hornet Herbal “Ecstasy” Drink Subject Of FDA Consumer Alert
Liquid product Green Hornet, marketed by Kekio Inc. as an herbal equivalent to the illegal street drug "ecstasy," was the subject of an 1FDA consumer alert Feb. 25 designating the product an unapproved drug
New EU Filings
Obecabtagene autoleucel, Autolus Therapeutics’s investigational treatment for relapsed or refractory B cell precursor acute lymphoblastic leukemia, is among the latest products that have been filed for review by the European Medicines Agency for potential EU marketing approval.
P&G Restores Volume Growth In Beauty, Grooming After Pricing Run
Procter & Gamble reports strong consumer spending in the US and Europe after a 3% increase in product pricing over the past year. Dragging on fiscal third-quarter results, sales of SK-II in China fell 30% for the January-March period, while lower incidence of cough and cold impacted Health Care performance.